SCHEMBL18996

SCHEMBL18996

CCCCCCOC(=O)CCC(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.66
NAAA Q02083 1/20 0.64
DGKA P23743 1/20 0.64
PAM P19021 2/20 0.58
GPR84 Q9NQS5 7/20 0.56
PPARG P37231 7/20 0.56
PPARD Q03181 7/20 0.56
PPARA Q07869 7/20 0.56
HDAC11 Q96DB2 5/20 0.56
TSHR P16473 4/20 0.56
PTPN1 P18031 3/20 0.56
ALDH1A1 P00352 2/20 0.56
TLR2 O60603 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
FABP4 P15090 2/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
SLC22A8 Q8TCC7 1/20 0.56
MEN1 O00255 1/20 0.56
ESR1 P03372 1/20 0.56
ALOX15 P16050 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL643820 1.00 HTR2C (0.66) HTR2CNAAADGKAPAMGPR84
SCHEMBL7954252 1.00 HTR2C (0.66) HTR2CNAAADGKAPAMGPR84
SCHEMBL67579 1.00 HTR2C (0.66) HTR2CNAAADGKAPAMGPR84
SCHEMBL7034679 1.00 HTR2C (0.66) HTR2CNAAADGKAPAMGPR84
SCHEMBL10868296 1.00 HTR2C (0.66) HTR2CNAAADGKAPAMGPR84
SCHEMBL7170043 1.00 HTR2C (0.66) HTR2CNAAADGKAPAMGPR84
SCHEMBL187665 1.00 HTR2C (0.66) HTR2CNAAADGKAPAMGPR84
SCHEMBL9257236 1.00 HTR2C (0.66) HTR2CNAAADGKAPAMGPR84
SCHEMBL3031778 1.00 HTR2C (0.66) HTR2CNAAADGKAPAMGPR84
SCHEMBL339257 1.00 HTR2C (0.66) HTR2CNAAADGKAPAMGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118530412-A Binder for negative electrode, negative electrode slurry, negative electrode, and lithium battery 深圳好电科技有限公司 2024-08-23 CN claimed
US-12595226-B2 Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents MODERNATX, INC. (US) 2026-04-07 US disclosed
US-20260069549-A1 COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS MODERNATX INC (US) 2026-03-12 US disclosed
EP-4031521-B1 CARBONATE CONTAINING LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS MODERNATX INC (US) 2025-12-24 EP disclosed
EP-4186888-B1 COMPOUND AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS MODERNATX INC (US) 2025-11-26 EP disclosed
US-20250228777-A1 COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS ARES CAPITAL CORPORATION, AS AGENT 2025-07-17 US disclosed
US-12337294-B2 Preparation method of super absorbent polymer composition LG CHEM, LTD. (KR) 2025-06-24 US disclosed
US-12324859-B2 Compounds and compositions for intracellular delivery of therapeutic agents MODERNATX, INC. (US) 2025-06-10 US disclosed
US-12312293-B2 Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents MODERNATX, INC. (US) 2025-05-27 US disclosed
CN-119931726-A Smoke-reducing fuel composition and application thereof 中国石油化工股份有限公司 2025-05-06 CN disclosed
US-20030087786-A1 High concentration monoester peroxy dicarboxylic acid compositions, use solutions, and methods employing them ECOLAB USA INC. 2003-05-08 US disclosed
US-20030021853-A1 In situ mono-or diester dicarboxylate compositions ECOLAB USA INC. 2003-01-30 US disclosed
WO-2003005817-A2 HIGH CONCENTRATION MONOESTER PEROXY DICARBOXYLIC ACID COMPOSITIONS, USE SOLUTIONS, AND METHODS EMPLOYING THEM ECOLAB INC. (US) 2003-01-23 WO disclosed
WO-2003005818-A1 IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS ECOLAB INC. (US) 2003-01-23 WO disclosed
EP-0414600-A1 Nematicidal products INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) 1991-02-27 EP disclosed
US-4639414-A Heat developable light-sensitive material FUJI PHOTO FILM CO., LTD. (JP) 1987-01-27 US disclosed
US-4307028-A Preparation of organo-tin compounds SOCIETE NATIONALE ELF AQUITAINE (FR) 1981-12-22 US disclosed
US-4256795-A A SUPPORTED LABEL COMPRISING A CURABLE LAYER OF A POLYESTERURETHANE BASED ON A LINEAR POLYESTER AND A DIPHENYL DIISOCYANATE, AN ACID CATALYST, AND A CURING AGENT; MARKING TEXTILES POLYMARK CORPORATION (US) 1981-03-17 US disclosed
US-4098817-A OXIDATION OF CYCLOALIPHATIC COMPOUNDS PETRO-TEX CHEMICAL CORPORATION (US) 1978-07-04 US disclosed
US-4096077-A LUBRICATING OILS, BENZOTRIAZOLES, HALF-ACIDS, HALF-ESTERS, HALF-AMIDES, HALF-THIOESTERS STANDARD OIL COMPANY (INDIANA) (US) 1978-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12324859-B2 Compounds and compositions for intracellular delivery of therapeutic agents LNPK, PLTP, PLIN3 HTR2C 4865/4885NAAA 3623/4885DGKA 186/4885
US-12312293-B2 Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents PLTP, LNPK, PLIN3 HTR2C 4867/4885NAAA 2955/4885DGKA 1377/4885
US-12595226-B2 Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents LNPK, PCTP, PLTP HTR2C 4594/4885NAAA 3493/4885DGKA 2490/4885
US-20260069549-A1 COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS SIN3A, PLIN3, MSR1 HTR2C 3948/4885NAAA 4410/4885DGKA 2480/4885
US-20030021853-A1 In situ mono-or diester dicarboxylate compositions DDC, HCAR3, ACMSD HTR2C 4223/4885NAAA 88/4885DGKA 109/4885
US-20250228777-A1 COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS LNPK, PLTP, PLIN3 HTR2C 4865/4885NAAA 3623/4885DGKA 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.